2. janssen johnson &amp; johnson ad26.cov2.s: approved 42 countries 10 trials 17 countries 3. moderna mrna-1273: approved 49 countries 21 trials 4 countries 4. oxford/astrazeneca azd1222: approved 99 countries 31 trials 18 countries